Rings Market is projected to achieve a value of USD 32.56 Million in 2023, with
a linear behavior in the market growth it is forecasted to achieve a value of
USD 46.32 Million by 2033 with a CAGR of 4.1% during the forecast period
rings, used in cardiac surgery, especially in the repair or reconstruction of
heart valves, are medical tools. These devices aim to provide support and
remodel the structure of heart valves, notably the mitral or tricuspid valves,
which might have sustained damage due to conditions like regurgitation or
prolapse. In the course of an annuloplasty procedure, a surgeon may utilize an
annuloplasty ring to aid in reinstating the natural shape and function of the
valve. These rings are typically crafted from materials like metal or polymers
and are available in various shapes and sizes to suit different patient
anatomies and specific valve repair needs.
expansion of the global market for annuloplasty repair devices is primarily
being fueled by the growing need for minimally invasive percutaneous mitral
valve annuloplasty and favorable health reimbursement policies. Additionally,
the increasing incidence of cardiac diseases, resulting in a higher frequency
of cardiac surgeries, is anticipated to continue propelling the growth of the
global annuloplasty repair devices market in the forecasted period. As per the
American Heart Association, more than 26,000 trans catheter aortic valve
replacements were conducted in the United States between the years 2011 and
2014 following the initial FDA approval.
valve regurgitation, a prevalent heart valve ailment among older individuals,
can result from either an infection or tissue degeneration. This condition
prompts the backward flow of blood into the heart and typically advances
progressively. In situations of heart valve regurgitation, intervention such as
annuloplasty or valve replacement becomes necessary to avert permanent damage
to the heart. The escalating elderly population is likely to augment the
instances of cardiovascular ailments necessitating annuloplasty treatment.
These factors are projected to steer the market's growth in the anticipated
period. Moreover, the market is experiencing positive growth due to new product
introductions and strategic initiatives by key market players.
market for annuloplasty systems underwent considerable disturbances as a
consequence of the COVID-19 pandemic. Stringent lockdowns and government
regulations led to a reduction in the volume of cardiac surgeries. Annuloplasty
systems are essential components in heart repair surgeries, and the pandemic
caused a notable decline in the number of patients seeking surgical procedures
at hospitals or clinics.
Market Size in 2023
Market Forecast in 2033
CAGR % 2024-2033
Consumption, company share, company heatmap, company production capacity,
growth factors and more
By Product, By End-user and by regional
Prevalence of Heart Valve Disorder
Advancements in minimally invasive and robotic-assisted surgical techniques have made heart valve repair and replacement more accessible.
Innovations in annuloplasty ring design, materials, and sizing options have enhanced their effectiveness and safety. These technological advancements attract both surgeons and patients.
North America, Europe, APAC, South
America and Middle East and Africa
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria
BioStable Science and Engineering Inc., Abbott
Laboratories, Boston Scientific Corp.,Valcare Medical, AFFLUENT MEDICAL, Micro
Interventional Devices Inc., Genesee BioMedical Inc., Edwards Lifesciences
Corp., Braile Biomedica, Medtentia International Ltd Oy, Medtronic Plc. And
growing prevalence of cardiovascular diseases significantly contributes to the
demand for annuloplasty rings. Heart and blood vessel conditions encompass a
range of health issues affecting these systems and are primary contributors to
global mortality and illness. This increase in such conditions has resulted in
an escalated requirement for medical interventions such as annuloplasty rings.
These devices address valve irregularities commonly associated with
there's a concerning increase in cardiovascular diseases, attributable to
sedentary lifestyles, poor dietary choices, smoking, and heightened stress
levels. Conditions like heart failure, coronary artery disease, and
hypertension contribute to valve irregularities such as tricuspid and mitral
regurgitation. These valve-related issues impede the heart's efficiency and can
lead to symptoms such as fatigue, breathing complications, and potentially
efforts are pivotal in driving the growth of the annuloplasty rings market.
These initiatives involve regulatory structures, financial support, and
favorable policies. Entities such as the FDA in the US or the CE marking in the
EU establish safety benchmarks and simplify authorization procedures, promoting
the creation and implementation of cutting-edge annuloplasty rings.
State-sponsored funding for research and development nurtures the production of
more sophisticated, economical devices. Moreover, reimbursement policies play a
substantial role in influencing acceptance rates among both healthcare
providers and patients.
the annuloplasty rings market is significantly influenced by patient
preferences and their outcomes. Patients now take an active role in their
healthcare decisions, emphasizing treatments with improved results and quicker
recovery. Their inclination towards minimally invasive procedures and durable,
effective devices shapes market dynamics. The demand for annuloplasty rings is
substantially affected by patient-centric elements, including decreased
post-operative issues, enhanced quality of life, and sustained success rates.
This prompts manufacturers to innovate, creating rings that meet these
preferences by concentrating on materials, designs, and methods that improve
the diagnoses of cardiovascular diseases (CVD) increase, there is a rising
demand for effective treatments. Annuloplasty rings play a crucial role in addressing
valvar insufficiencies as they uphold the structure and functionality of the
heart. These rings are employed in surgical procedures to repair and reshape
the annulus, the ring-shaped area where the heart valve connects to the heart
and Development (R&D) is a critical component within the annuloplasty rings
market. Continuous R&D endeavors are geared toward transforming these
cardiac devices, concentrating on enhancing materials, refining designs, and
crafting individualized solutions for patients. Progress in biocompatible
materials and inventive designs is fostering the production of annuloplasty
rings that are more robust, adaptable, and efficient. With a dedicated focus on
enhancing patient outcomes and life quality, the R&D domain signifies a
critical prospect, steering the forthcoming expansion and innovation in the
annuloplasty rings market.
Market By Product Analysis
product, the Annuloplasty Rings Market is Categories into Tricuspid valve
repair devices, Mitral valve repair devices. Mitral valve repair devices segment
accounts for the largest share of around 51% in 2022.
valve conditions like regurgitation and stenosis are quite frequent. Among
these, mitral regurgitation, involving the backward flow of blood through the
valve, stands as one of the most commonly encountered heart valve issues.
Market End-User Analysis
End-user, the Annuloplasty Rings Market is Categories into Hospitals,
Ambulatory surgical centers, Speciality clinics. The Hospital segment accounts
for the largest share of around 68% in 2022.
rings are predominantly utilized in surgical procedures aimed at rectifying
heart valve issues, particularly in medical facilities equipped with cardiac
surgery departments. These specialized interventions are primarily conducted in
hospital settings, thereby elevating the need for annuloplasty rings.
Market Regional Analysis
America dominate the Annuloplasty Rings Market with the highest revenue
generating market with share of more than 43%. The market is largely led by
North America, due to its advance healthcare system, constant technological
advancements, and significant investment in healthcare. The United States and
Canada, both equipped with a strong medical technology industry, host prominent
research institutions, top-notch medical device producers, and a highly skilled
workforce. This setting greatly supports the progress and enhancement of annuloplasty
rings within the region.
stands as the second-largest dominant region in the market for annuloplasty
rings due to its robust healthcare infrastructure, elevated rates of cardiac
conditions, rigorous regulatory standards, the presence of major market
players, and ongoing innovation within the industry.
Asia-Pacific region is emerging as a developing area in the Annuloplasty Rings
Market due to its rising healthcare spending, growing healthcare
infrastructure, substantial population base, the arrival of significant
industry players, government initiatives, and advancements in technology and
Annuloplasty Rings Market is dominated by a few large companies, such as BioStable
Science and Engineering Inc., Abbott Laboratories, Boston Scientific Corp., Valcare
Medical, AFFLUENT MEDICAL, Micro Interventional Devices Inc., Genesee
BioMedical Inc., Edwards Lifesciences Corp., Braile Biomedica, Medtentia
International Ltd Oy, Medtronic Plc and other.
There Are Some Of The Recent Developments Of The Annuloplasty
2022, Cardiac Implants LLC announced the successful first deployment of its
innovative Tri-Ring percutaneous annuloplasty device, utilized alongside a
therapeutic adjustment technique.
2021, Valcare Medical, a firm specializing in transcatheter mitral and tricuspid
valve replacement and repair technologies, has achieved a milestone by
conducting the inaugural trans-septal delivery of the AMEND annuloplasty ring
in a human patient.
Report Following Segments:
Market, By Product
Tricuspid valve repair
Mitral valve repair
Market, By End-User
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Annuloplasty Rings Market was valued at USD 30.24 million in 2022.
Annuloplasty Rings Market size will increase at approximate CAGR of 4.1% during the forecasted period.
BioStable Science and Engineering Inc., Abbott Laboratories, Boston Scientific Corp., Valcare Medical, AFFLUENT MEDICAL, Micro Interventional Devices Inc., Genesee BioMedical Inc., Edwards Lifesciences Corp., Braile Biomedica, Medtentia International Ltd Oy, Medtronic Plc and other.
North America dominates the market with an active share of 43%.
Only Three Thousand Nine Hundred Fifty US dollar
Only Four Thousand Nine Hundred Fifty US dollar
Only Five Thousand Nine Hundred Fifty US dollar